Greg Tourangeau - May 6, 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role: Controller
Signature: /s/ Gregory Tourangeau
Stock symbol: FULC
Transactions as of: May 6, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/10/2022, 04:15 PM
Previous filing: Mar 14, 2022
Next filing: Jul 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FULC	Common Stock	Award	$0	+3.25K	+25.09%	$0.00	16.2K	May 6, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FULC	Stock Option (right to buy)	Award	$0	+6.5K		$0.00	6.5K	May 6, 2022	Common Stock	6.5K	$8.63	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock unit (RSU) awards granted on May 6, 2022, with each RSU representing a right to receive one share of common stock. The RSU is subject to time-based vesting with (i) 25% of the shares vesting on May 6, 2023, (ii) 25% of the shares vesting on May 6, 2024, and (iii) 50% of the shares vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date.
F2	This option was granted on May 6, 2022 and is subject to time-based vesting, with (i) 25% of the options vesting on May 6, 2023, (ii) 25% of the options vesting on May 6, 2024, and (iii) 50% of the options vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date.

Content

These shares represent restricted stock unit (RSU) awards granted on May 6, 2022, with each RSU representing a right to receive one share of common stock. The RSU is subject to time-based vesting with (i) 25% of the shares vesting on May 6, 2023, (ii) 25% of the shares vesting on May 6, 2024, and (iii) 50% of the shares vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date.

This option was granted on May 6, 2022 and is subject to time-based vesting, with (i) 25% of the options vesting on May 6, 2023, (ii) 25% of the options vesting on May 6, 2024, and (iii) 50% of the options vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date.